Literature DB >> 20022691

Cross-talk between miRNA and Notch signaling pathways in tumor development and progression.

Zhiwei Wang1, Yiwei Li, Dejuan Kong, Aamir Ahmad, Sanjeev Banerjee, Fazlul H Sarkar.   

Abstract

Notch signaling pathways are known to regulate many cellular processes, including cell proliferation, apoptosis, migration, invasion, and angiogenesis, and is one of the most important signaling pathway during normal development. Recently, emerging evidences suggest that microRNAs (miRNAs) can function as key regulators of various biological and pathologic processes during tumor development and progression. Notch signaling has also been reported to be regulated through cross-talk with many pathways and factors where miRNAs appears to play a major role. This article will provide a brief overview of the published evidences for the cross-talks between Notch and miRNAs. Further, we summarize how targeting miRNAs by natural agents could become a novel and safer approach for the prevention of tumor progression and treatment. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022691      PMCID: PMC2857527          DOI: 10.1016/j.canlet.2009.11.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  88 in total

1.  Off the beaten pathway: the complex cross talk between Notch and NF-kappaB.

Authors:  Clodia Osipo; Todd E Golde; Barbara A Osborne; Lucio A Miele
Journal:  Lab Invest       Date:  2007-12-03       Impact factor: 5.662

Review 2.  Notch signaling.

Authors:  Lucio Miele
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

3.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

4.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

Authors:  Mark Bloomston; Wendy L Frankel; Fabio Petrocca; Stefano Volinia; Hansjuerg Alder; John P Hagan; Chang-Gong Liu; Darshna Bhatt; Cristian Taccioli; Carlo M Croce
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

5.  Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  Stephen Kalscheuer; Xiaoxiao Zhang; Yan Zeng; Pramod Upadhyaya
Journal:  Carcinogenesis       Date:  2008-09-09       Impact factor: 4.944

6.  Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

Authors:  Yiwei Li; Timothy G VandenBoom; Dejuan Kong; Zhiwei Wang; Shadan Ali; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

7.  miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

Authors:  Elena Gallardo; Alfons Navarro; Nuria Viñolas; Ramon M Marrades; Tania Diaz; Bernat Gel; Angels Quera; Eva Bandres; Jesus Garcia-Foncillas; Jose Ramirez; Mariano Monzo
Journal:  Carcinogenesis       Date:  2009-09-07       Impact factor: 4.944

8.  Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

Authors:  Valery Tarasov; Peter Jung; Berlinda Verdoodt; Dmitri Lodygin; Alexey Epanchintsev; Antje Menssen; Gunter Meister; Heiko Hermeking
Journal:  Cell Cycle       Date:  2007-05-11       Impact factor: 4.534

9.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Authors:  Minoru Toyota; Hiromu Suzuki; Yasushi Sasaki; Reo Maruyama; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

10.  miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.

Authors:  Dejuan Kong; Yiwei Li; Zhiwei Wang; Sanjeev Banerjee; Aamir Ahmad; Hyeong-Reh Choi Kim; Fazlul H Sarkar
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

View more
  58 in total

1.  miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.

Authors:  J Gao; N Li; Y Dong; S Li; L Xu; X Li; Y Li; Z Li; S S Ng; J J Sung; L Shen; J Yu
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

2.  miRNA-34c regulates Notch signaling during bone development.

Authors:  Yangjin Bae; Tao Yang; Huan-Chang Zeng; Philippe M Campeau; Yuqing Chen; Terry Bertin; Brian C Dawson; Elda Munivez; Jianning Tao; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2012-04-12       Impact factor: 6.150

3.  The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells.

Authors:  Simone Brabletz; Karolina Bajdak; Simone Meidhof; Ulrike Burk; Gabriele Niedermann; Elke Firat; Ulrich Wellner; Arno Dimmler; Gerhard Faller; Jörg Schubert; Thomas Brabletz
Journal:  EMBO J       Date:  2011-01-11       Impact factor: 11.598

4.  γ-secretase inhibition combined with cisplatin enhances apoptosis of nasopharyngeal carcinoma cells.

Authors:  Jun-Xu Zhou; Ji-Bo Han; Shi-Ming Chen; Yu Xu; Yong-Gang Kong; Bo-Kui Xiao; Ze-Zhang Tao
Journal:  Exp Ther Med       Date:  2011-12-06       Impact factor: 2.447

5.  MicroRNA-215 inhibits relapse of colorectal cancer patients following radical surgery.

Authors:  Shan Li; Jing Gao; Jin Gu; Jiajia Yuan; Dong Hua; Lin Shen
Journal:  Med Oncol       Date:  2013-03-27       Impact factor: 3.064

Review 6.  Dll4-Notch signaling in regulation of tumor angiogenesis.

Authors:  Zhaoguo Liu; Fangtian Fan; Aiyun Wang; Shizhong Zheng; Yin Lu
Journal:  J Cancer Res Clin Oncol       Date:  2013-10-10       Impact factor: 4.553

Review 7.  Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy.

Authors:  Li Li; Ping Tang; Shun Li; Xiang Qin; Hong Yang; Chunhui Wu; Yiyao Liu
Journal:  Med Oncol       Date:  2017-09-16       Impact factor: 3.064

8.  MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.

Authors:  Juan Sandoval; Angel Díaz-Lagares; Rocío Salgado; Octavio Servitje; Fina Climent; Pablo L Ortiz-Romero; Amparo Pérez-Ferriols; Maria P Garcia-Muret; Teresa Estrach; Mar Garcia; Lara Nonell; Manel Esteller; Ramon M Pujol; Blanca Espinet; Fernando Gallardo
Journal:  J Invest Dermatol       Date:  2014-11-18       Impact factor: 8.551

Review 9.  MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.

Authors:  Min Cao; Lijuan Zheng; Jianzhou Liu; Thomas Dobleman; Shen Hu; Vay Liang W Go; Ge Gao; Gary Guishan Xiao
Journal:  Clin Oral Investig       Date:  2018-01-03       Impact factor: 3.573

Review 10.  MicroRNA-224: as a potential target for miR-based therapy of cancer.

Authors:  Wei Chen; Xue-Mei Fan; Ling Mao; Jun-Ying Zhang; Jian Li; Jian-Zhong Wu; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2015-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.